Modern Engineering Marvels on MSN

Alien signals, real comet: What 3I/ATLAS revealed

About 470,000 “interesting” radio hits can still add up to zero. That was the practical outcome when astronomers aimed one of ...
Author Shawn Peters blends clarity and rigor to make data structures and algorithms accessible to all learners. COLORADO, CO, UNITED STATES, January 2, 2026 /EINPresswire.com/ — Vibrant Publishers ...
VAST is a library for program analysis and instrumentation of C/C++ and related languages. VAST provides a foundation for customizable program representation for a broad spectrum of analyses. Using ...
Supporting SMEs in 2026, BDSLCCI introduces new cybersecurity features and governance guidelines for safer business operations. Cybersecurity is essential for every business, regardless of its size, ...
When Jake Flowers walked off the ICCU Dome turf in late November, it was the culmination of a project that started 29 years ...
Some key parts of Kennesaw State University’s mission are to advance knowledge, foster innovation and serve the community.
Abstract: Federated learning enables training across multiple entities while ensuring data security and the effectiveness of knowledge dissemination. Despite its benefits, it remains susceptible to ...
The fungal species Candida auris is spreading across the globe, and gaining in virulence - but there are strategies available ...
At the core of every AI coding agent is a technology called a large language model (LLM), which is a type of neural network ...
Abstract: On-site rapid detection of cells is especially of concern for many fields; image-based detection results can directly reflect multidimensional information such as cell contour and ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...